118 related articles for article (PubMed ID: 17557144)
1. The innate cellular responses to HIV-1 invasion: emerging molecules of ancient defense mechanisms.
Simm M
Arch Immunol Ther Exp (Warsz); 2007; 55(3):131-8. PubMed ID: 17557144
[TBL] [Abstract][Full Text] [Related]
2. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 and AIDS: what are protective immune responses?
Beattie T; Rowland-Jones S; Kaul R
J HIV Ther; 2002 May; 7(2):35-9. PubMed ID: 12553686
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
Sáez-Cirión A; Sinet M; Shin SY; Urrutia A; Versmisse P; Lacabaratz C; Boufassa F; Avettand-Fènoël V; Rouzioux C; Delfraissy JF; Barré-Sinoussi F; Lambotte O; Venet A; Pancino G;
J Immunol; 2009 Jun; 182(12):7828-37. PubMed ID: 19494307
[TBL] [Abstract][Full Text] [Related]
5. [A new veil removed from the physiologic mysteries of "HIV control" ].
Nau JY
Rev Med Suisse; 2007 Apr; 3(107):1017. PubMed ID: 17526378
[No Abstract] [Full Text] [Related]
6. The problem with antivirals alone.
TreatmentUpdate; 1999 Mar; 11(2):1-2. PubMed ID: 11366774
[TBL] [Abstract][Full Text] [Related]
7. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis puzzle.
Simmons P
Res Initiat Treat Action; 1999 Oct; 5(4):13-4. PubMed ID: 11366937
[TBL] [Abstract][Full Text] [Related]
9. Monoubiquitinated histone H1B is required for antiviral protection in CD4(+)T cells resistant to HIV-1.
Lesner A; Kartvelishvili A; Lesniak J; Nikolov D; Kartvelishvili M; Trillo-Pazos G; Zablotna E; Simm M
Biochemistry; 2004 Dec; 43(51):16203-11. PubMed ID: 15610014
[TBL] [Abstract][Full Text] [Related]
10. The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?
Sheppard N; Sattentau Q
Expert Rev Mol Med; 2005 Feb; 7(2):1-21. PubMed ID: 15710051
[TBL] [Abstract][Full Text] [Related]
11. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
[TBL] [Abstract][Full Text] [Related]
12. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
13. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
[TBL] [Abstract][Full Text] [Related]
15. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
[TBL] [Abstract][Full Text] [Related]
16. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
Ciuffreda D; Comte D; Cavassini M; Giostra E; Bühler L; Perruchoud M; Heim MH; Battegay M; Genné D; Mulhaupt B; Malinverni R; Oneta C; Bernasconi E; Monnat M; Cerny A; Chuard C; Borovicka J; Mentha G; Pascual M; Gonvers JJ; Pantaleo G; Dutoit V
Eur J Immunol; 2008 Oct; 38(10):2665-77. PubMed ID: 18958874
[TBL] [Abstract][Full Text] [Related]
17. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.
Zhang L; Yu W; He T; Yu J; Caffrey RE; Dalmasso EA; Fu S; Pham T; Mei J; Ho JJ; Zhang W; Lopez P; Ho DD
Science; 2002 Nov; 298(5595):995-1000. PubMed ID: 12351674
[TBL] [Abstract][Full Text] [Related]
18. Relationship of frequency of CD4+CD25+Foxp3+ regulatory T cells with disease progression in antiretroviral-naive HIV-1 infected Chinese.
Zhang Z; Jiang Y; Zhang M; Shi W; Liu J; Han X; Wang Y; Jin X; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):391-2. PubMed ID: 18806350
[TBL] [Abstract][Full Text] [Related]
19. Altered immunological reactivity in HIV-1-exposed uninfected neonates.
Hygino J; Lima PG; Filho RG; Silva AA; Saramago CS; Andrade RM; Andrade DM; Andrade AF; Brindeiro R; Tanuri A; Bento CA
Clin Immunol; 2008 Jun; 127(3):340-7. PubMed ID: 18356112
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the gamma c cytokine network in T cells during HIV infection.
Sirskyj D; Thèze J; Kumar A; Kryworuchko M
Cytokine; 2008 Jul; 43(1):1-14. PubMed ID: 18417356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
